Life Sciences
Research conducted at Mayo Clinic has provided new information about life sciences
Published in Medical Device Law Weekly, November 9th, 2008
New research, 'Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain,' is the subject of a report. According to recent research from the United States, "NT69L, is a novel neurotensin (8-13) analog that participates in the modulation of the dopaminergic pathways implicated in addiction to psychostimulants. NT69L blocks nicotine-induced hyperactivity as well as the initiation and expression of sensitization in rats."
"Recent evidence suggests that stimulation of mesocorticolimbic dopamine system, with influences from the other monoamine systems, e.g. norepinephrine and serotonin, is involved in nicotine's reinforcing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
More Articles from Medical Device Law Weekly
- Anti-Infectives
Nektar Sells Pulmonary Business to Novartis for $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder - Breast Cancer
Metropolitan Chicago Breast Cancer Task Force Reports on Progress Toward Reducing the Black-White Disparity in Breast Cancer Mortality and Improving Breast Health for All Women - Cardiology
Jacc Intervention Publishes Mivs Vestasync I Trial Preliminary Results - Glancy Binkow & Goldberg Llp
Glancy Binkow & Goldberg LLP, Representing Shareholders of the Spectranetics Corporation, Announces an Expanded Class Period in the Shareholder Lawsuit - Memento, Inc.
Memento and IBM Join Forces to Help Financial Institutions Fight Fraud - NuVasive, Inc.
Nuvasive Reports Third Quarter 2008 Financial Results - More from this issue of Medical Device Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
